Acute pharmacological elevation of serotonin (5-hydroxytryptamine; 5-HT) activity decreases operant responding for primary reinforcers, suggesting that 5-HT reduces incentive motivation. The mechanism by which 5-HT alters incentive motivation is unknown, but parallel evidence that 5-HT 2C receptor agonists also reduce responding for primary reinforcers implicates this receptor as a potential candidate. These experiments examined whether chronic and acute disruptions of serotonin transporter (SERT) activity altered incentive motivation, and whether the 5-HT 2C receptor mediated the effects of elevated 5-HT on behavior. To assess incentive motivation, we measured responding for three different reinforcers: a primary reinforcer (saccharin), a conditioned reinforcer (CRf), and an unconditioned sensory reinforcer (USRf). In the chronic condition, responding was compared between SERT knockout (SERT-KO) mice and their wild-type littermates. In the acute condition, responding was examined in wild-type mice following treatment with 10 or 20 mg/kg citalopram, or its vehicle. The ability of the selective 5-HT 2C antagonist SB 242084 to prevent the effects of SERT-KO and citalopram on responding was subsequently examined. Both SERT-KO and citalopram reduced responding for saccharin, a CRf, and a USRf. Treatment with SB 242084 enhanced responding for a CRf and a USRf in SERT-KO mice and blocked the effects of citalopram on CRf and USRf responding. However, SB 242084 was unable to prevent the effects of SERT-KO or citalopram on responding for saccharin. These results support a powerful inhibitory function for 5-HT in the control of incentive motivation, and indicate that the 5-HT 2C receptor mediates these effects of 5-HT in a reinforcer-dependent manner.
INTRODUCTION
The monoamine neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) has been implicated in the control of several psychological and behavioral processes. Many lines of evidence suggest that reward-related behaviors are particularly sensitive to modulation by 5-HT. Treatment with selective serotonin reuptake inhibitors (SSRIs) or the 5-HT releaser dexfenfluramine consistently decreases instrumental responding for primary reinforcers such as food (Thompson, 1977) , drugs of abuse (Carroll et al, 1990; Richardson and Roberts, 1991) , and brain stimulation reward (Lee and Kornetsky, 1998; McClelland et al, 1989) . Conversely, suppression of 5-HT activity can facilitate responding for various primary reinforcers (Lyness et al, 1980; Poschel and Ninteman, 1971; Wogar et al, 1991) . These findings suggest that 5-HT broadly inhibits incentive motivation-the process by which motivationally significant stimuli elicit appetitive behaviors.
Through incentive motivational processes, environmental stimuli can influence goal-directed behavior. For example, environmental stimuli that are paired with the acquisition of primary reinforcers acquire motivational significance through Pavlovian conditioning. Such stimuli can elicit appetitive behaviors and support instrumental responding as conditioned reinforcers (CRfs; Taylor and Robbins, 1986) . Some environmental stimuli may also possess intrinsic motivational significance, since they can support instrumental behaviors on their own in the absence of prior conditioning (Browne et al, 2016; Olsen and Winder, 2009; Stewart, 1960) . These stimuli can be termed unconditioned sensory reinforcers (USRfs) to emphasize their lack of conditioned incentive value.
Whether an environmental stimulus serves as a CRf or a USRf likely depends on two separate incentive motivational processes. In the context of conditioning, a stimulus that is repeatedly presented to an animal but not paired with reward delivery does not support subsequent instrumental responding (Beninger and Ranaldi, 1992; Browne et al, 2014; Mead and Stephens, 2003) . Therefore, conditioning is necessary for a stimulus to acquire incentive properties and serve as a CRf, while non-contingent exposure to a stimulus prevents its ability to support responding as a USRf. Rearing animals in isolation also differentially affects responding for a CRf and a USRf (Browne et al, 2016) , indicating that these serve as distinct reinforcers.
The motivational significance of environmental stimuli can be altered by changes in 5-HT activity. Treatment with dexfenfluramine reduces responding for a CRf (Fletcher, 1995; Wilson et al, 2000) , while whole-brain 5-HT neuron ablation enhances this behavior (Fletcher et al, 1999) . In tests of drug-seeking behavior, dexfenfluramine and the SSRI fluoxetine also diminished the ability of a cocaine-paired stimulus to reinstate responding under extinction conditions (Baker et al, 2001; Burmeister et al, 2003) . Furthermore, we have recently shown that another SSRI, citalopram, reduced responding for a CRf and a USRf (Browne et al, 2016) . Therefore, the ability of 5-HT to suppress incentive motivation appears to extend from primary reinforcers to other types of motivationally significant stimuli.
Most of the previous studies investigating the effects of elevated 5-HT activity on motivational processes have used acute pharmacological challenges. In contrast, Sanders et al (2007) demonstrated a sustained reduction in operant responding for food following both chronic SSRI treatment and constitutive knockout of the serotonin transporter (SERT-KO), which produces a chronic, 6-fold elevation in extracellular 5-HT (Bengel et al, 1998; Fabre et al, 2000; Shen et al, 2004) . These studies provide an additional line of evidence to support a major inhibitory role for 5-HT in regulating food-motivated behavior.
Serotonergic neurotransmission is mediated through multiple 5-HT receptor subtypes (Barnes and Sharp, 1999) . The 5-HT 2C receptor appears to have a particularly important role in regulating incentive motivation. Treatment with 5-HT 2C receptor agonists attenuates operant responding for food (Grottick et al, 2000) , nicotine (Fletcher et al, 2012) , ethanol (Tomkins et al, 2002) , cocaine (Cunningham et al, 2011; Manvich et al, 2012) , and brain stimulation reward (Zeeb et al, 2015) . These 5-HT 2C receptor agonists also suppress cue-induced reinstatement of drug-seeking (Fletcher et al, 2012; Grottick et al, 2000; Neisewander and Acosta, 2007) , and responding for CRfs (Guy and Fletcher, 2014) . Therefore, 5-HT may suppress incentive motivation through 5-HT 2C receptor signaling.
The present experiments had two primary objectives. The first objective was to characterize the effects of chronic and acute increases in 5-HT activity on incentive motivation elicited by three types of reinforcer. Thus, we measured operant responding for saccharin, responding for a CRf, and responding for a USRf. The second objective was to establish a mechanistic role for the 5-HT 2C receptor in mediating the effects of elevated 5-HT activity. Four separate experiments were used to address these objectives. Experiments 1 and 2 examined the effects of SERT-KO and acute citalopram treatment, respectively, on responding for all three reinforcers. In Experiment 3, we examined whether the effects of SERT-KO or citalopram could be blocked by the selective 5-HT 2C receptor antagonist SB 242084. Experiment 4 was conducted to confirm that SERT-KO mice exhibited a functional SERT deletion, and that the doses of citalopram used in Experiments 2 and 3 were SERT-selective.
MATERIALS AND METHODS

Animals
A total of 102 male C57BL/6 mice were used. In SERT-KO experiments, homozygous SERT null mutant mice and their wild-type (WT) littermates were used. SERT-KO mice were generated in-house through heterozygous crosses. Founder SERT-KO mice were derived from a 129 ES cell line bearing a targeted deletion of the SLC6A4 gene, which had been backcrossed to the C57BL/6J background for at least 25 generations (Jackson Laboratory, Bar Harbor, Maine). In citalopram experiments, WT C57BL/6N mice from Charles River Laboratories (Quebec, QC) were used. Responding for each type of reinforcer was examined in separate cohorts of mice. All mice were pair housed in a temperature and humidity controlled room on a 12-h light-dark cycle with lights on at 0700 h. Throughout behavioral testing, all mice had restricted water access such that water was available for 2 h each day, beginning 1 h after completion of behavioral procedures. This ensured that mice were in the same physiological state across all tests. Food was available ad libitum. This work adhered to the guidelines of the Canadian Council on Animal Care, and protocols were approved by the Centre for Addiction and Mental Health Animal Care Committee.
Apparatus
All testing was conducted in 12 operant conditioning boxes (Med Associates, St Albans, Vermont) measuring 22 × 18 × 13 cm. On the front wall of the chamber, a reinforcer magazine containing an infrared photodetector and roof-mounted light was centred 2.5 cm above the floor. A motor-driven dipper could be raised to deliver 0.02 ml of liquid through a hole in the magazine floor. Two retractable levers flanked the magazine, and a yellow LED stimulus light was positioned above each lever. The box was illuminated by a houselight, and was enclosed in a sound-attenuating chamber equipped with a ventilation fan.
Drugs
Citalopram HBr (Toronto Research Chemicals, Toronto, Canada) was dissolved in 0.9% saline. SB 242084 (Tocris, Bristol, UK) was dissolved in a solution of 0.9% saline and 8% hydroxypropyl-β-cyclodextrin by sonication. All doses are expressed in terms of the free base. Both drugs were administered intraperitoneally in a volume of 10 ml/kg. Citalopram was administered 20 min before testing while SB 242084 was administered 40 min before testing. Unless otherwise described, all drug treatments followed a withinsubjects design with dose order determined from a Latin Square. Drug treatment sessions were separated by 72 h.
General Behavioral Testing Procedures
Responding for primary reinforcement. Mice were first acclimatized to water restriction for 2 weeks and were given access to a bottle containing saccharin (0.2% w/v in tap water) three times for 2 h in their homecage to reduce neophobia during subsequent behavioral testing. Mice next underwent two daily sessions where they were trained to retrieve 0.02 ml saccharin from the dipper. Here, the dipper was raised for 8 s 60 times according to a random time (RT) 30-s schedule.
Testing. Mice were placed into operant chambers with two response levers present. Responses on the active lever could activate the dipper which remained accessible for 3 s. Responses on the inactive lever had no programmed consequence. In 40-min sessions, mice were first trained to lever press for saccharin on a fixed-ratio 1 (FR1) schedule of reinforcement until they had acquired 430 saccharin presentations in two consecutive sessions. The mice were then shifted to testing phases on random ratio 2 (RR2; average number of responses required for reinforcer delivery) and RR4 schedules of reinforcement.
Responding for conditioned reinforcement. Before any behavioral procedures, mice were acclimatized to water restriction for 2 weeks, received access to saccharin three times in their homecage, and underwent two daily sessions in which they were trained to retrieve saccharin from the dipper. The conditioned reinforcement paradigm involved two phases: Pavlovian conditioning and operant conditioning. Behavioral procedures followed previously described methods (Browne et al, 2014) .
Pavlovian conditioning. Mice received 14 daily 40-min sessions in which a conditioned stimulus (CS) was presented just before the delivery of saccharin 30 times on an RT 60-s schedule. The compound CS consisted of houselight off, both stimulus lights on for 5 s, and the sound of the mechanical dipper being operated. The main dependent variables measured were head entries into the reward magazine during the 5-s CS period (before saccharin delivery) and head entries during a 5-s period just before CS onset (PreCS period).
Operant conditioning. Following Pavlovian conditioning, the ability of the CS to now support responding as a CRf was assessed. Two response levers were introduced to the operant chambers. Responding on the active lever could produce a shortened version of the CS (5-s period with the houselight off and both stimulus lights on, and an elevation of the empty dipper during the last 2 s) initially on an RR2 schedule of reinforcement. Responding on the inactive lever had no programmed consequence. The first session of this phase lasted until 10 active lever responses were made or after 40 min elapsed. This session served to familiarize mice with the response levers and minimize confounding novelty on the subsequent test days (Fletcher, 1995; Kelley and Delfs, 1991) . Data from this session were not presented. Each subsequent test was carried out in 40-min sessions with no limits on responding.
Responding for unconditioned sensory reinforcement. Mice were acclimatized to water restriction for 2 weeks before tests of responding for a USRf. Behavioral procedures followed previously described methods (Browne et al, 2016) .
Testing. Mice naive to behavioral testing were placed in operant chambers with two response levers presented. Responding on the active lever could produce the USRf: 5-s stimulus compound consisting of houselight off, both yellow stimulus lights on for 5 s, and the sound of the dipper during the last 2 s. This stimulus compound was chosen to be exactly the same as the stimulus serving as a CRf, but the dipper was always empty. Responding on the inactive lever had no programmed consequence. Each test session lasted 60 min. Mice first acquired responding on an FR1 schedule of reinforcement for six sessions, and this was changed to an RR2 schedule for the remainder of testing.
Experiment 1: Responding for Saccharin, a CRf, and a USRf in SERT-KO Mice
Responding for saccharin. SERT-KO mice (n = 12) and WT littermates (n = 12) were first tested on an RR2 schedule of reinforcement for five sessions, followed by five sessions on an RR4 schedule.
Responding for a CRf. During Pavlovian conditioning, approach to the reward magazine across 14 sessions was compared between SERT-KO mice (n = 11) and WT littermates (n = 10). In the operant conditioning phase, responding for the CS serving as a CRf was compared between genotypes on an RR2 schedule of reinforcement for three sessions followed by an RR4 schedule for three more sessions.
Responding for a USRf. SERT-KO mice (n = 12) and WT littermates (n = 12) received six acquisition sessions on an FR1 schedule of reinforcement, followed by seven test sessions on an RR2 schedule.
Experiment 2: Responding for Saccharin, a CRf, and USRf-Effects of Acute Citalopram
Responding for saccharin. Mice (n = 10) first underwent baseline testing for five sessions on both RR2 and RR4 schedules of reinforcement. Subsequently, the effect of 10 and 20 mg/kg citalopram and its vehicle was tested over three more sessions on the RR4 schedule.
Responding for a CRf. Following Pavlovian conditioning, mice (n = 12) received four baseline sessions of responding for a CRf on an RR2 schedule of reinforcement (data not shown). The effect of 10 and 20 mg/kg citalopram and its vehicle was then tested over three more sessions on the RR2 schedule.
Responding for a USRf. Mice (n = 12) first acquired responding for a USRf on an FR1 schedule of reinforcement over six sessions followed by seven more sessions on an RR2 schedule. Subsequently, the effect of 10 and 20 mg/kg citalopram and its vehicle was tested over three more sessions on the RR2 schedule.
Experiment 3: Role of the 5-HT 2C Receptor in Mediating the Effects of SERT-KO and Citalopram on Operant Responding
Responding for saccharin. Responding on an RR4 schedule of reinforcement was compared between SERT-KO mice and WT littermates following treatment with 1 mg/kg SB 242084 or its vehicle. In the citalopram condition, mice were treated with 1 mg/kg SB 242084 or its vehicle before 10 mg/kg citalopram or its vehicle (four treatment conditions) and tested on an RR4 schedule of reinforcement.
Responding for a CRf. Responding on an RR4 schedule of reinforcement was compared between SERT-KO mice and WT littermates following treatment with 1 mg/kg SB 242084 or its vehicle. Here, 1 mg/kg SB 242084 did not significantly alter responding in WT mice. However, in mice used for the citalopram study, we found that this dose of SB 242084 significantly elevated responding above control levels (data not shown). For this reason, mice were treated with 0.25 mg/kg SB 242084 or its vehicle before 10 mg/kg citalopram or its vehicle (four treatment conditions) and tested on the RR2 schedule of reinforcement.
Responding for a USRf. We had concerns that SERT-KO mice may not have acquired the behavior well enough for a single SB 242084 challenge to alter responding. Therefore, we used a repeated treatment design wherein SERT-KO mice and WT littermates were tested for three sessions with vehicle, and then five sessions with 1 mg/kg SB 242084. In the citalopram condition, mice were treated with 1 mg/kg SB 242084 or its vehicle before 10 mg/kg citalopram or its vehicle (four treatment conditions) and tested on the RR2 schedule of reinforcement.
Experiment 4: Confirmation of SERT-KO and SERT-Selective Doses of Citalopram
In SERT-KO mice and WT littermates, the effects of 10 and 20 mg/kg citalopram or its vehicle on responding for saccharin (RR4 schedule of reinforcement), a CRf (RR2 schedule), and a USRf (RR2 schedule) were examined.
Data Analysis
Statistical analyses were performed using Statistica (v7). Data were analyzed using two-and three-way repeated measures ANOVAs, with Session, CSvsPreCS (Pavlovian conditioning), Lever (active or inactive), Dose, or Treatment (in pharmacological blocking experiments) as within-subject measures and Genotype as a between-subjects measure when applicable. In Experiment 3, data for SERT-KO mice and WT littermates were analyzed separately as we hypothesized that SB 242084 treatment would produce changes in operant responding in SERT-KO mice but not in WT littermates. Where repeated SB 242084 treatment was used in Experiment 3, separate ANOVAs were conducted across vehicle or SB 242084 conditions for SERT-KO mice and WT littermates. No significant main effect of session was observed in any case. Therefore, ANOVAs were conducted using means averaged across the three vehicle and five SB 242084 treatment sessions. Post hoc pairwise comparisons were performed using the Tukey's honest significant difference test. Significance was set at po0.05 for all analyses. Responding for a CRf. During Pavlovian conditioning, SERT-KO mice and WT littermates showed similar rates of learned approach to the reward magazine upon CS presentation (Figure 1c ; CSvsPreCS × Session: F (13,247) = 14.61, po0.001; Genotype: F (1,19) = 0.13, ns). However, in the operant conditioning phase, SERT-KO mice made fewer responses for the CRf compared with WT littermates (Figure 1d ). This effect was moderate at the RR2 schedule (Genotype: F (1,19) = 3.44, p = 0.079), but reached statistical significance on the more demanding RR4 schedule (Genotype: F (1,19) = 6.51, po0.05).
Responding for a USRf. SERT-KO mice made significantly fewer responses for a USRf compared with WT littermates on both FR1 (Figure 1e 
Experiment 2: Responding for Saccharin, a CRf, and USRf-Effects of Acute Citalopram
Responding for saccharin. Mice acquired stable responding on RR2 and RR4 schedules of reinforcement ( Figure 2a ; Lever: F (1,9) 484.10, po0.001), and citalopram decreased active lever responding on the RR4 schedule (Figure 2b ; Dose × Lever: F (2,18) = 22.27, po0.001). Post hoc tests confirmed that 10 and 20 mg/kg doses decreased active lever responses compared with vehicle (both po0.001).
Responding for a CRf. During Pavlovian conditioning, mice learned to approach the reward magazine upon CS presentation (Figure 2c ; Session × CSvPreCS: F (1,13) = 18.11, po0.001). In the operant conditioning phase, mice selectively responded for the CRf over four baseline sessions (data not shown; Lever: F (1,11) = 20.28, po0.001). Citalopram significantly decreased responding for the CRf (Figure 2d ; Dose × Lever: F (2,22) = 15.52, po0.001) at both 10 and 20 mg/kg doses compared with vehicle (both po0.001).
Responding for a USRf. Mice made more responses on the active lever compared with the inactive lever on both FR1 (F (1,11) = 11.43, po0.01) and RR2 (F (1,11) = 7.64, po0.05) schedules of reinforcement (Figure 2e ). Citalopram significantly decreased responding for the USRf on the RR2 schedule (Figure 2f ; Dose × Lever: F (2,22) = 8.02, po0.01) at both the 10-and 20-mg/kg doses compared with vehicle (both po0.001; Figure 2f ).
Experiment 3: Role of the 5-HT 2C Receptor in Mediating the Effects of SERT-KO and Citalopram on Operant Responding
Responding for saccharin. Treatment with 1 mg/kg SB 242084 had no effect in either SERT-KO mice (Figure 3a ; Dose: F (1,11) = 0.24, p40.05) or WT littermates (Dose: F (1,11) = 0.16, p40.05). Similarly, 1 mg/kg SB 242084 did not completely block the ability of 10 mg/kg citalopram to reduce responding (Figure 3b) . The citalopram-SB 242084 condition was not significantly different from vehicle-vehicle, but was also not significantly different from vehicle-citalopram (both p40.05).
Responding for a CRf. Treatment with 1 mg/kg SB 242084 increased active lever responding in SERT-KO mice by 95% (Figure 3c ; Treatment × Lever: F (1,10) = 10.37, po0.01; Figure 1 SERT-KO reduces responding for saccharin, a conditioned reinforcer (CRf), and an unconditioned sensory reinforcer (USRf). (a and b) Responses made on the active lever delivering saccharin (filled symbols) and the inactive lever (empty symbols) by SERT-KO mice (gray lines; n = 12) and WT littermates (black lines; n = 12) on random ratio 2 (RR2) and RR4 schedules of reinforcement. (c) Reward magazine entries made by SERT-KO mice (n = 11) and WT littermates (n = 10) during the 5-s CS presentation before saccharin delivery (CS; filled symbols) or a 5-s period just before CS onset (Pre-CS; empty symbols) in the Pavlovian conditioning phase of the conditioned reinforcement procedure. (d) Responding on a lever delivering the CS now serving as a CRf (active lever; filled symbols) and an inactive lever (empty symbols) by SERT-KO and WT mice on RR2 and RR4 schedules of reinforcement. (e and f) Responses made on the active lever delivering the USRf (filled symbols) and the inactive lever (empty symbols) by SERT-KO mice (n = 12) and WT littermates (n = 12) on FR1 and RR2 schedules of reinforcement. Data are expressed in terms of the mean ± SEM. † Po0.05 main effect of Genotype.
Treatment: F (1,10) = 6.20, po0.05), but had no effect in WT littermates (Treatment × Lever: F (1,9) = 1.70, ns; Treatment: F (1,9) = 2.87, ns). Similarly, 0.25 mg/kg SB 242084 blocked the inhibitory effects of citalopram on responding (Figure 3d ). The SB 242084-citalopram condition was significantly different from vehicle-citalopram (po0.001), but not vehicle-vehicle (p40.80).
Responding for a USRf. Data from repeated treatment conditions were averaged across vehicle and SB 242084 sessions. SB 242084 increased active lever responding in SERT-KO mice by 128% compared with vehicle ( Figure 3e ; Treatment × Lever: F (1, 11) = 7.28, po0.05; Treatment: F (1,11) = 10.24, po0.01), but had no effect in WT littermates (Treatment × Lever: F (1,11) = 2.35, ns; Treatment: F (1,11) = 3.93, ns). Treatment with 1 mg/kg SB 242084 completely blocked the ability of citalopram to decrease responding for a USRf (Figure 3f ; po0.05). The SB 242084-citalopram condition was significantly different from vehicle-citalopram (po0.001), but not vehicle-vehicle (p40.49). Figure 4 shows the effect of citalopram on responding for saccharin (a), a CRf (b), and a USRf (c) in SERT-KO mice and their WT littermates. Citalopram reduced responding for all three reinforcers in WT but not in SERT-KO mice (all Dose × Genotype interactions F47.99, po0.01). Post hoc tests found that both 10 and 20 mg/kg citalopram decreased active lever responses for all three reinforcers in WT mice (all po0.001), but SERT-KO mice were unaffected at either dose (all p40.34).
Experiment 4: Confirmation of SERT-KO and SERT-Selective Doses of Citalopram
DISCUSSION
The majority of evidence that 5-HT inhibits responding for various primary reinforcers has come from studies using acute pharmacological manipulations, such as treatment with dexfenfluramine or SSRIs. Genetic deletion of the SERT produces a selective 4-to 6-fold elevation in extracellular 5-HT levels (Bengel et al, 1998; Fabre et al, 2000; Shen et al, 2004) , providing a selective method of examining how chronically elevated 5-HT contributes to behavior. In the present experiments, responding for the primary reinforcer saccharin was reduced in SERT-KO mice, consistent with findings from Sanders et al (2007) that SERT-KO mice exhibit reduced food-reinforced behavior.
In the Pavlovian conditioning phase of the conditioned reinforcement procedure, mice learned to approach the reward magazine when saccharin availability was signaled by a CS. This discriminated approach behavior suggests that animals learned the predictive significance of the CS. SERT-KO mice and WT littermates acquired discriminated approach behavior at similar rates. However, compared with WT littermates, SERT-KO mice made fewer responses for the CS when it was subsequently used as a CRf. Together, these findings demonstrate that chronically elevated 5-HT does not alter associative stimulus-reward learning, but impairs the ability of a reward-associated stimulus to elicit incentive motivation.
SERT-KO mice consistently made fewer responses for a USRf throughout testing compared with WT littermates. Importantly, this lower responding in SERT-KO mice cannot be the result of a generalized learning deficit. In addition to exhibiting no impairments in stimulus-reward learning, SERT-KO mice readily acquired action-outcome contingencies based on their ability to respond for saccharin and a CRf. Furthermore, while responding was reduced, SERT-KO mice still demonstrated selective responding on the lever delivering the USRf.
Acute citalopram treatment at doses that selectively disrupted SERT function (Figure 4 ) greatly reduced responding for saccharin, a CRf, and a USRf. The findings from tests of responding for saccharin are consistent with previous reports that SSRIs and dexfenfluramine reduce responding for various primary reinforcers (Lee and Kornetsky, 1998; Richardson and Roberts, 1991; Thompson, 1977) . Decreased responding for a CRf and USRf following citalopram treatment is also consistent with previous studies (Baker et al, 2001; Browne et al, 2016; Fletcher, 1995) , further supporting the notion that acute elevation of 5-HT activity generally reduces the motivational significance of incentive stimuli.
The reinforcers used in these experiments elicited different levels of operant responding. This was most apparent when comparing response magnitudes for saccharin vs a CRf or a USRf. From the ability of saccharin to elicit more appetitive behavior than a CRf or a USRf, it can be inferred that saccharin has a higher incentive value than a CRf or a USRf. This differential response magnitude has two important implications for interpreting the behavioral effects of elevated 5-HT activity.
The first implication is for considering whether the observed effects in SERT-KO mice are due to motor impairments. Previous studies have suggested that SERT-KO mice exhibit reduced rotarod performance and locomotor activity (Holmes et al, 2002; Lira et al, 2003; Morelli et al, 2011) . However, as previously suggested by Sanders et al (2007) , motor incapacitation is an unlikely explanation for the lower operant response rate in SERT-KO mice. SERT-KO mice made substantially more responses (albeit at reduced level compared with WT controls) for saccharin than for a CRf and a USRf, and their responding for saccharin increased when the schedule of reinforcement was increased from RR2 to RR4 (see Figure 1 ). This suggests that SERT-KO mice can make more responses for each reinforcer, but that SERT disruption alters the ability of each reinforcer to elicit responding at levels comparable to WT animals.
The second implication is for interpreting the role of 5-HT 2C receptors in mediating the effects of enhanced 5-HT activity. Blockade of the 5-HT 2C receptor was sufficient to reverse some effects of SERT-KO and prevent the effects of citalopram on responding for a CRf and a USRf. Conversely, 5-HT 2C receptor blockade did not alter the effects of either manipulation on responding for saccharin. Therefore, the involvement of 5-HT 2C receptors in mediating the effects of 5-HT may scale with the incentive value of the stimulus: the higher the reinforcer value, the less specific involvement of 5-HT 2C .
The inability of SB 242084 to completely block the effects of elevated 5-HT on responding for saccharin may be related to the complexity of neurobiological mechanisms in place to control responding for highly valuable incentives. For example, feeding behavior is influenced by several neurotransmitters, neuromodulators, and peptides (Schwartz et al, 2000) . In addition to the 5-HT 2C receptor, 5-HT 1A and 5-HT 1B receptors have been implicated in the control of food intake, brain-stimulation reward, and the reinforcing properties of drugs of abuse (Dourish et al, 1986; Harrison et al, 1999; Lee et al, 2002; Montgomery et al, 1991; Peltier and Schenk, 1993; Rocha et al, 1998) . Therefore, 5-HT may inhibit incentive motivation for highly valuable reinforcers through multiple receptor systems.
The present findings that 5-HT 2C receptors do not mediate the inhibitory influence of elevated 5-HT on responding for saccharin appear to be at odds with many studies showing that 5-HT 2C receptor agonists impair responding for food (Grottick et al, 2000; Wolff and Leander, 2000) . One explanation for this disparity is that 5-HT 2C receptor agonists may artificially drive 5-HT 2C neurotransmission to a greater extent than is achieved through endogenous 5-HT activity. Nevertheless, the ability of SB 242084 to block the effects of SERT-KO and citalopram on responding for a CRf and a USRf is consistent with 5-HT 2C receptor agonist studies (Guy and Fletcher, 2014; Neisewander and Acosta, 2007) , and support a specific role for 5-HT 2C receptors in these behaviors.
Serotonergic influences on incentive motivation may be mediated through interactions with the mesolimbic dopamine system. Dopamine neurons in the ventral tegmental area (VTA) are activated by reinforcing stimuli, and inhibiting dopamine action in the nucleus accumbens impairs rewardrelated behaviors (Schultz, 1998; Wise and Rompre, 1989) . Manipulations of mesolimbic dopamine system activity alter all three behaviors measured in the present experiments (Olsen and Winder, 2009; Salamone and Correa, 2002; Taylor and Robbins, 1984) . The VTA receives dense 5-HT innervation and exhibits high levels of 5-HT 2C receptor expression (Bubar and Cunningham, 2007) . Extensive electrophysiological and neurochemical findings demonstrate that 5-HT 2C receptor agonists decrease mesolimbic dopamine system activity, while antagonists moderately increase accumbens dopamine release (Di Matteo et al, 2001) . Therefore, 5-HT action at 5-HT 2C receptors may reduce motivation by suppressing mesolimbic dopamine system activity.
The present results support the 5-HT 2C receptor as a potential therapeutic target for treating disorders that present with dysregulated motivational processes, such as addiction, schizophrenia, and depression. The 5-HT 2C receptor agonist lorcaserin reduces feeding behavior (Grottick et al, 2000) and has been approved for the treatment of obesity. However, the ability of lorcaserin to reduce motivation may extend to nonfood reinforcers: lorcaserin reduces responding for drugs of abuse such as cocaine and nicotine, and prevents reinstatement of responding for these drugs following periods of abstinence (as reviewed by Higgins et al, 2013) . A recent study also demonstrates that the 5-HT 2C receptor antagonist SB 242084 enhances motivation under certain circumstances (Bailey et al, 2015) . Consistent with this, the present experiments demonstrate that some 5-HT-mediated deficits in incentive motivation can be reversed by treatment with SB 242084. Therefore, the 5-HT 2C receptor may be a bidirectional therapeutic target for dysregulated motivation: 5-HT 2C receptor agonists could be used to treat pathologically high motivation (eg, in addiction), while 5-HT 2C receptor antagonists could potentially be used to treat pathologically low motivation (eg, in depression).
In conclusion, these experiments demonstrate that 5-HT activity broadly reduces incentive motivation irrespective of reinforcer identity or value. However, the 5-HT 2C receptor mediates the effects of 5-HT in a reinforcer-dependent manner; 5-HT 2C signaling reduces the motivation elicited by a reinforcer based on its incentive value. Together, these results bridge the gap between parallel lines of research examining the effects of 5-HT itself and 5-HT 2C agonists on incentive motivation, and support a powerful role for 5-HT in the inhibitory control of motivated behavior.
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